SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 134 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 1,175,000 | $26,273,000 | 6.18% |
| Aisling Capital Management LP | 1,025,000 | $22,919,000 | 4.12% |
| FRAZIER MANAGEMENT LLC | 1,435,045 | $32,088,000 | 2.57% |
| Avidity Partners Management LP | 3,846,000 | $85,997,000 | 2.38% |
| COMMODORE CAPITAL LP | 236,500 | $5,288,000 | 2.11% |
| ACUTA CAPITAL PARTNERS, LLC | 255,180 | $5,706,000 | 2.06% |
| Boxer Capital, LLC | 2,287,782 | $51,155,000 | 1.74% |
| Altium Capital Management LP | 253,448 | $5,667,000 | 1.57% |
| Affinity Asset Advisors, LLC | 190,500 | $4,260,000 | 1.45% |
| VR Adviser, LLC | 591,782 | $13,232,000 | 1.44% |
| Nantahala Capital Management | 2,002,410 | $44,774,000 | 1.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 638,093 | $14,268,000 | 1.09% |
| HealthCor Management, L.P. | 1,371,480 | $30,666,000 | 1.08% |
| PFM Health Sciences, LP | 1,484,227 | $33,187,000 | 1.01% |
| Tri Locum Partners LP | 180,261 | $4,031,000 | 1.00% |
| 683 Capital Management, LLC | 835,000 | $18,670,000 | 0.99% |
| Avoro Capital Advisors LLC | 2,500,000 | $55,900,000 | 0.96% |
| Eventide Asset Management | 2,016,993 | $45,100,000 | 0.67% |
| Casdin Capital, LLC | 1,000,000 | $22,360,000 | 0.67% |
| Sio Capital Management, LLC | 146,142 | $3,268,000 | 0.66% |
External links
This page lists SYNDAX PHARMACEUTICALS INC's shareholders in Q1 2021. To view SYNDAX PHARMACEUTICALS INC's shareholder history, click here.